The briefing
WHO vaccine experts urged a full-scale human trial of Ervebo to test whether it provides cross-protection against the strain driving the Ebola outbreak in the Democratic Republic of the Congo. The evaluation aims to determine effectiveness beyond the vaccine’s originally targeted strain.
Original headline
WHO urges Ervebo vaccine trial in DR Congo Ebola outbreak